Advisory Board May 12, 2023
An FDA advisory committee on Wednesday unanimously recommended the agency approve the first over-the-counter (OTC) birth control pill, a move that was praised by many health experts and would significantly expand access to contraception nationwide.
FDA advisory panel endorses OTC birth control
Over two days of deliberation, members of two FDA advisory committees considered whether patients could safely and effectively take the birth control drug Opill without first consulting a healthcare provider.
Opill, which is manufactured by Perrigo’s HRA Pharma, is a progestin-only pill. Progestin is a synthetic version...